Patents by Inventor Laurent Derre

Laurent Derre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Soluble HLA-E Molecules And Their Use For Diagnosing And Treating Pathologies
    Publication number: 20090081226
    Abstract: The present invention relates to a purified soluble HLA-E molecule, characterized in that: it is a monomeric protein, it presents a sequence identity of at least 80% with membrane-bound HLA-E (SEQ ID NO: 1), it has a molecular weight from about 36 kDa to about 42 kDa, it binds to the CD94/NKG2A receptor.
    Type: Application
    Filed: December 16, 2005
    Publication date: March 26, 2009
    Applicant: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICLE)
    Inventors: Beatrice Charreau, Stephanie Coupel, Nadine Gervois, Laurent Derre, Francine Jotereau
  • Peptides for use in antitumor immunotherapy
    Publication number: 20060122119
    Abstract: The invention concerns the use of immunogenic peptides representing T epitopes presented by the MHC I, derived from Melan-A, MAGE-A6, gp 100, tyrosinase and NY-ESO-1 antigens for the diagnosis or treatment of melanomas in HLA-B35 subjects.
    Type: Application
    Filed: March 4, 2003
    Publication date: June 8, 2006
    Applicants: Institut Nat'l De La Sante Et De La Recherche Med., Universite De Nantes
    Inventors: Boris Linard, Francine Jotereau, Houssem Benlalam, Elizabeth Diez, Yannick Guilloux, Nathalie Labarriere, Nadine Gervois, Laurent Derre